| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.005 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |